cannavalon

PRESS RELEASE – May 10, 2018 9:00 AM/PM EASTERN Cannavalon Biosciences, Inc.  “Affinity Bio Partners and HCXP selected for Cannavalon Biosciences Proof of Concept Epilepsy Clinical Study” LOCATION Santa Rosa, California. –(BUSINESS WIRE)— Cannavalon Biosciences, Inc. announced today that it has selected Affinity Bio Partners, LLC as their Clinical Research Organization and their technology partner,…

© HCXP Inc 2017 All Rights Reserved.